Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 May;74(5):2089–2093. doi: 10.1073/pnas.74.5.2089

Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

L Chedid, M Parant, F Parant, P Lefrancher, J Choay, E Lederer
PMCID: PMC431080  PMID: 325566

Abstract

N-Acetylmuramyl-L-alanyl-D-isoglutamine and four other synthetic adjuvants that are structural analogs of part of the mycobacterial peptidoglycan monomer are shown to enhance the nonspecific immunity of mice infected by Klebsiella pneumoniae. These compounds are active by various routes, including oral administration; they are also effective when administered after challenge. Of the seventeen other analogs tested, none is able to increase significantly resistance to infection, although seven of these molecules are adjuvant-active in saline. Previous results have shown that in contrast to lipopolysaccharides, these synthetic adjuvants are devoid of immunogenicity, mitogenicity, and toxicity in normal or adrenalectomized mice.

Full text

PDF
2089

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam A., Ciorbaru R., Petit J. F., Lederer E. Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis. Proc Natl Acad Sci U S A. 1972 Apr;69(4):851–854. doi: 10.1073/pnas.69.4.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adam A., Devys M., Souvannavong V., Lefrancier P., Choay J., Lederer E. Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers. Biochem Biophys Res Commun. 1976 Sep 7;72(1):339–346. doi: 10.1016/0006-291x(76)90999-2. [DOI] [PubMed] [Google Scholar]
  3. Adlam C., Broughton E. S., Scott M. T. Enhanced resistance of mice to infection with bacteria following pre-treatment with Corynebacterium parvum. Nat New Biol. 1972 Feb 16;235(59):219–220. doi: 10.1038/newbio235219a0. [DOI] [PubMed] [Google Scholar]
  4. Audibert F., Chédid L., Lefrancier P., Choay J. Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components. Cell Immunol. 1976 Feb;21(2):243–249. doi: 10.1016/0008-8749(76)90053-8. [DOI] [PubMed] [Google Scholar]
  5. Azuma I., Sugimura K., Yamamura Y., Kusumoto S., Tarumi Y. Adjuvant activity of synthetic cell-wall peptidoglycan subunits on monoazobenzenearsonate-N-acetyl-L-tyrosine and bacterial alpha-amylase in guinea pigs. Jpn J Microbiol. 1976 Feb;20(1):63–66. doi: 10.1111/j.1348-0421.1976.tb00909.x. [DOI] [PubMed] [Google Scholar]
  6. Bekierkunst A. Proceedings: Induction of granuloma with mycobacterial fractions, non-specific resistance and the immune response to unrelated antigens. Ann Sclavo. 1971 Nov-Dec;13(6):795–808. [PubMed] [Google Scholar]
  7. Blanden R. V., Lefford M. J., Mackaness G. B. The host response to Calmette-Guérin bacillus infection in mice. J Exp Med. 1969 May 1;129(5):1079–1107. doi: 10.1084/jem.129.5.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chedid L., Audibert F., Lefrancier P., Choay J., Lederer E. Modulation of the immune response by a synthetic adjuvant and analogs. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2472–2475. doi: 10.1073/pnas.73.7.2472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chedid L., Parant M., Parant F. Augmentation de la résistance non spécifique à l'infection de la souris après administration orale de deux glycopeptides synthétiques doués d'activité adjuvante. C R Acad Sci Hebd Seances Acad Sci D. 1977 Jan 31;284(5):405–408. [PubMed] [Google Scholar]
  10. Chedid L., Parant M., Parant F., Boyer F. A proposed mechanism for natural immunity to enterobacterial pathogens. J Immunol. 1968 Feb;100(2):292–306. [PubMed] [Google Scholar]
  11. Chedid L., Parant M., Parant F., Gustafson R. H., Berger F. M. Biological study of a nontoxic, water-soluble immunoadjuvant from mycobacterial cell walls. Proc Natl Acad Sci U S A. 1972 Apr;69(4):855–858. doi: 10.1073/pnas.69.4.855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DUBOS R. J., SCHAEDLER R. W. Effects of cellular constituents of mycobacteria on the resistance of mice to heterologous infections I. Protective effects. J Exp Med. 1957 Nov 1;106(5):703–717. doi: 10.1084/jem.106.5.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. DUBOS R. J., SCHAEDLER R. W. Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins. J Exp Med. 1956 Jul 1;104(1):53–65. doi: 10.1084/jem.104.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Elin R. J., Wolff S. M., Chedid L. Nonspecific resistance to infection induced in mice by a water-soluble adjuvant derived from Mycobacterium smegmatis. J Infect Dis. 1976 May;133(5):500–505. doi: 10.1093/infdis/133.5.500. [DOI] [PubMed] [Google Scholar]
  15. Ellouz F., Adam A., Ciorbaru R., Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317–1325. doi: 10.1016/0006-291x(74)90458-6. [DOI] [PubMed] [Google Scholar]
  16. FREUND J. The mode of action of immunologic adjuvants. Bibl Tuberc. 1956;(10):130–148. [PubMed] [Google Scholar]
  17. Fauve R. M., Hevin B. Immunostimulation with bacterial phospholipid extracts. Proc Natl Acad Sci U S A. 1974 Feb;71(2):573–577. doi: 10.1073/pnas.71.2.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. HOWARD J. G., BIOZZI G., HALPERN B. N., STIFFEL C., MOUTON D. The effect of Mycobacterium tuberculosis (BCG) infection on the resistance of mice to bacterial endotoxin and Salmonella enteritidis infection. Br J Exp Pathol. 1959 Jun;40(3):281–290. [PMC free article] [PubMed] [Google Scholar]
  19. Hiu I. J. Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity. Nat New Biol. 1972 Aug 23;238(86):241–242. doi: 10.1038/newbio238241a0. [DOI] [PubMed] [Google Scholar]
  20. JOHNSON A. G., GAINES S., LANDY M. Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide. J Exp Med. 1956 Feb 1;103(2):225–246. doi: 10.1084/jem.103.2.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kotani S., Watanabe Y., Kinoshita F., Shimono T., Morisaki I. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids. Biken J. 1975 Jun;18(2):105–111. [PubMed] [Google Scholar]
  22. Kotani S., Watanabe Y., Shimono T., Harada K., Shiba T. Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids. Biken J. 1976 Mar;19(1):9–13. [PubMed] [Google Scholar]
  23. Lederer E. Cord factor and related trehalose esters. Chem Phys Lipids. 1976 Mar;16(2):91–106. doi: 10.1016/0009-3084(76)90001-3. [DOI] [PubMed] [Google Scholar]
  24. Merser C., Sinay P., Adam A. Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1975 Oct 27;66(4):1316–1322. doi: 10.1016/0006-291x(75)90503-3. [DOI] [PubMed] [Google Scholar]
  25. Migliore-Samour D., Jollès P. A hydrosoluble, adjuvant-active mycobacterial "polysaccharide-peptidoglycan". Preparation by a simple extraction technique of the bacterial cells (strain Peurois). FEBS Lett. 1972 Sep 15;25(2):301–304. doi: 10.1016/0014-5793(72)80509-x. [DOI] [PubMed] [Google Scholar]
  26. PARANT M., BOYER F., CHEDID L. AUGMENTATION DE LA R'ESISTANCE AUX INFECTIONS CONS'ECUTIVE 'A UNE INJECTION D'ENDOTOXINE. MISE EN 'EVIDENCE DU M'ECANISME PAR L'ASSOCIATION DE SULFAMIDE. C R Hebd Seances Acad Sci. 1965 Mar 1;260:2630–2633. [PubMed] [Google Scholar]
  27. Parant M., Parant F., Chedid L., Minor L. L. Immunostimulants bactériens et protection de la souris infectée par Klebsiella pneumoniae résistante aux antibiotiques par mutation ou par transfert de plasmides. Ann Immunol (Paris) 1975 Apr;126(3):319–326. [PubMed] [Google Scholar]
  28. Stewart-Tull D. E., Shimono T., Kotani S., Kato M., Ogawa Y., Yamamura Y., Koga T., Pearson C. M. The adjuvant activity of a non-toxic, water-soluble glycopeptide present in large quantities in the culture filtrate of Mycobacterium tuberculosis strain DT. Immunology. 1975 Jul;29(1):1–15. [PMC free article] [PubMed] [Google Scholar]
  29. WEISS D. W., BONHAG R. S., PARKS J. A. STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A MENTHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG). I. ANTIMICROBIAL PROTECTION. J Exp Med. 1964 Jan 1;119:53–70. doi: 10.1084/jem.119.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES